Results 81 to 90 of about 438,283 (235)
‘TB or not TB?’ Problems of differential diagnosis of cutaneous mycobacteriosis and tuberculosis – A Case Study and interdisciplinary discussion [PDF]
, 2015 The diagnosis of cutaneous tuberculosis poses a serious challenge due to many skin diseases of different etiology resembling the lesions caused by the TB (tuberculosis) bacillus, and difficulties in confirming the disease.
Zofia Zwolska +11 more
core +1 more source
Mucosal‐Associated Invariant T Cells in Health and Disease
MedComm, Volume 7, Issue 10, October 2026.The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao +5 more
wiley +1 more source
Cutaneous Tuberculosis: Clinicopathologic Arrays and Diagnostic Challenges
Dermatology Research and Practice, 2018 The clinicopathological manifestations of cutaneous tuberculosis are diverse. The precise diagnosis is often overlooked, due to clinical presentations as those of cutaneous diseases with different etiology and the relative paucity of the pathogens in the
Priyatam Khadka +2 more
doaj +1 more source
Human resources for control of tuberculosis and HIV-associated tuberculosis. [PDF]
, 2005 The global targets for tuberculosis (TB) control were postponed from 2000 to 2005, but on current evidence a further postponement may be necessary.
Zachariah, R +7 more
core
INtraVESical immunoTherapy (INVEST) prior to radical cystectomy for bladder cancer: trial protocol
BJU International, Volume 138, Issue 4, Page 607-619, October 2026.Background High‐risk non‐muscle‐invasive bladder cancer (HRNMIBC) has a variable prognosis, managed predominantly by local surgical resection and intravesical Bacillus Calmette–Guérin (BCG), or radical cystectomy (RC). Current treatments are poorly tolerated, have supply limitations and often fail to control the disease.
Ruby Lister‐Whelan +13 more
wiley +1 more source
Indian Journal of Dermatology, 2010 Background: Cutaneous tuberculosis (TB) is essentially an invasion of the skin by Mycobacterium tuberculosis, the same bacteria that causes pulmonary tuberculosis.
Dwari Binayak +3 more
doaj
Contact Dermatitis, Volume 95, Issue 4, Page 349-357, October 2026.ABSTRACT Drug hypersensitivity reactions (DHRs) are common in children and are diagnostically challenging, with cutaneous manifestations being the most common presentation. Patch testing (PT) is a well‐established tool for investigating delayed T‐cell‐mediated reactions and is widely used in patients with contact dermatitis.
Gabriele Simonetti +7 more
wiley +1 more source
THE EFFECT OF DEVELOPMENT OF GEOGRAPHY, VITAMIN D, WEALTH, AND AGRICULTURAL PRODUCTIVITY ON TUBERCULOSIS MORTALITY: THE CASE OF THE 19TH CENTURY US [PDF]
Tuberculosis remains a major cause of international mortality, and researchers and policy advocates continue to seek a cost effective prevention and treatment.
Scott Alan Carson
core
International Journal of Dermatology, Volume 65, Issue 10, Page 2055-2065, October 2026.The clinical effects of selective IL‐23 inhibition in refractory pyoderma gangrenosum, highlighting progressive ulcer healing, reduction in inflammation and pain, and steroid‐sparing effect, supporting the role of the IL‐23/Th17 axis as a therapeutic target.
Luca Bettolini +25 more
wiley +1 more source
, 1911 Compiler: 1911- P.P. Jacobs.Directory for 1919 issued in 3 parts: 1. A directory of tuberculosis associations and committees in the United States. 2. A directory of dispensaries, clinics and classes for the special treatment of tuberculosis in the United
Jacobs, Philip Peter, 1879- comp. +1 more
core